2023-504393-37-00已完成1 期
A Multiple Dose Pharmacokinetic Study of AMX0035 in Participants with Impaired Renal Function and in Healthy Participants
Amylyx Pharmaceuticals EMEA B.V., Amylyx Pharmaceuticals Inc.1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2023年8月23日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 32
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Medical Information
Scientific
Amylyx Pharmaceuticals EMEA B.V.
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
1 期
Pharmacokinetic and Pharmacodynamic Study of AMX0035 in Patients With ALSALSNCT04987671Amylyx Pharmaceuticals Inc.14
招募中
1 期
AMX0035 and Progressive Supranuclear PalsyProgressive Supranuclear PalsyMedDRA version: 21.1Level: PTClassification code: 10036813Term: Progressive supranuclear palsy Class: 100000004852CTIS2023-505893-14-00Amylyx Pharmaceuticals Inc.600
已完成
1 期
A Study to Evaluate AMG 133 Administered Subcutaneously in Participants With Overweight or ObesityObesityNCT06976372Amgen120
已完成
不适用
COMPARISON OF SINGLE VERSUS MULTIPLE DOSE (AMOXICILLIN/CLAVULANIC ACID) ANTIMICROBIAL PROPHYLAXIS FOR CAESAREAN SECTION IN FEDERAL TEACHING HOSPITAL GOMBE, NIGERIA - A RANDOMIZED CONTROLLED TRIAPACTR202009483150226Sagir Muhammad176
进行中（未招募）
1 期
Pharmacokinetic Study of Single and Multiple Dose of PKL-021 Administered Orally to Healthy Subjects/A submitted trial is conducted on healthy subjectsMedDRA version: 21.1Level: PTClassification code: 10036312Term: Post-traumatic epilepsy Class: 100000004852MedDRA version: 22.1Level: PTClassification code: 10076982Term: Post stroke epilepsy Class: 100000004852CTIS2023-506633-30-00Pikralida Sp. z o.o.12